Applied Biosciences (OTCPK:APPB) - Stock Price, News & Analysis

APPB Stock Overview

Focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. More details

APPB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($21)

Shares are highly illiquid

Applied Biosciences Corp. Competitors

Plant-Based Investment

OTCPK:CWWB.F

US$27.0

PLx Pharma Winddown

OTCPK:PLXP.Q

US$30.0

MJ Holdings

OTCPK:MJNE

US$58.0

RVL Pharmaceuticals

OTCPK:RVLP.Q

US$111.0

Price History & Performance

Summary of all time highs, changes and price drops for Applied Biosciences
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000001
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-99.88%
5 Year Change	-100.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	APPB	US Pharmaceuticals	US Market
7D	0%	3.4%	1.6%
1Y	n/a	14.2%	32.3%

Return vs Industry: Insufficient data to determine how APPB performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how APPB performed against the US Market.

Price Volatility

Is APPB's price volatile compared to industry and market?
APPB volatility
APPB Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: APPB's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine APPB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	n/a	n/a	www.appliedbiocorp.com

Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It also delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The company was incorporated in 2014 and is based in Beverly Hills, California.

Applied Biosciences Corp. Fundamentals Summary

How do Applied Biosciences's earnings and revenue compare to its market cap?
APPB fundamental statistics
Market cap	US$21.00
Earnings (TTM)	-US$2.79m
Revenue (TTM)	US$859.86k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is APPB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
APPB income statement (TTM)
Revenue	US$859.86k
Cost of Revenue	US$331.55k
Gross Profit	US$528.31k
Other Expenses	US$3.31m
Earnings	-US$2.79m

Last Reported Earnings

Dec 31, 2019

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did APPB perform over the long term?

See historical performance and comparison